Novel vaccines against multiple subtypes of dengue virus

Details for Australian Patent Application No. 2009210624 (hide)

Owner VGX Pharmaceuticals, Inc.

Inventors Sardesal, Niranjan Y.; Ramanathan, Mathura P.

Agent Spruson & Ferguson

Pub. Number AU-A-2009210624

PCT Pub. Number WO2009/099716

Priority 61/020,490 11.01.08 US

Filing date 12 January 2009

Wipo publication date 13 August 2009

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/099716 Priority application(s): WO2009/099716

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210627-Compositions and methods for the treatment of tumor of hematopoietic origin

2009210606-Buckle and respirator using such buckle, having a deformable cinch bar, and method